newsfilter
← Latest News
GlobeNewswire·

Cassava Sciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

AUSTIN, Texas, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ:SAVA, "Cassava", the "Company")), a biotechnology company focused on developing novel, investigational treatments for central nervous